Texas Clinical Lab Settles $5.7 Million False Claims Act Judgment, Reinforces Importance of Regulatory Compliance

In a recent development, Texas Clinical Laboratory, BestCare Laboratory Services LLC, and its founder, have agreed to pay $5.7 million to settle a 2018 False Claims Act (FCA) judgement. Arising under the Department of Justice’s ability-to-pay policy, the judgement was imposed based on assertions of fraudulent claims to federal healthcare programs. This resolution seems poised…

Read More

National Asbestos Litigation Conference to Address Key Challenges and Trends

Legal professionals working in the asbestos litigation field are preparing to gather for the National Asbestos Litigation Conference, this year taking place from September 12th to 13th in Charleston, South Carolina. This two-day conference, highlighted in JD Supra, aims to bring together experts in the field to facilitate networking, knowledge-sharing, and discussions on the latest…

Read More

SEC Targets Crypto Trading Platforms in $1 Billion Unregistered Securities Case

The Securities and Exchange Commission (SEC) lodged a complaint on 31st July with the U.S. District Court for the Eastern District of New York against three cryptocurrency trading platforms, along with their founder. These entities are alleged to have partaken in unregistered offerings of crypto asset securities. The significant concern relates to the generated funding;…

Read More

Navigating Civil Procedure Statutes: Serving Summons in Cases Involving Unknown Business Entity Forms

In the complex landscape of corporate legal practice, understanding the nuances of civil procedure statutes often proves crucial. As per an article on JDSupra, the California Code of Civil Procedure provides general rules for the service of summons, outlined in Cal. Code Civ. Proc. ยงยง 415.10 – 415.95. Additionally, added layers of provisions come from…

Read More

Pharmaceutical Patent Litigation: The Balance Between Safety, Efficacy, and Innovation

In a recent case, United Therapeutics Corporation v. Liquidia Technologies, Inc., there was a discussion by the Federal Circuit on July 24 concerning the necessity for safety and efficacy within pharmaceutical method claims to be sufficiently enabled and backed by written description. This case was sparked when Liquidia Technologies filed a new Drug Application for…

Read More

California Proposition 65: Surge in Lawsuits Signifies Heightened Legal Risk for Businesses

Proposition 65, a California law that requires businesses to provide clear and reasonable health hazard warnings about significant exposures to certain chemicals, has been a contentious issue for various quarters. Particularly in the first half of 2023, a surge in lawsuits related to violations of this law has been noted. The occurrence suggests a growing…

Read More

Ruling Impacts Corporate Reactions to Lawsuits: The Fall of “Without Merit” Phrase

A recent ruling by the District of Massachusetts Court against software firm Pegasystems could have significant implications for corporate responses to lawsuits. Judge William Young is making headlines in the legal community for holding Pegasystems accountable for asserting the baselessness of a lawsuit despite its merit. This ruling could potentially alter the commonplace, reflexive response…

Read More

Supreme Court Rulings Leave Labor and Employment Law Questions Unanswered: Analyzing the Implications

In a series of recent rulings, the Supreme Court has dealt with significant labor and employment law issues, leaving lawyers and corporations unsure of their implications and how they will play out in practice. This report explores these decisions, and their potential impact on labor and employment law. With questions being asked more frequently in…

Read More